Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).

Details

Request a copyRequest a copy
Serval ID
serval:BIB_68C8171C3E09
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).
Journal
Leukemia
Author(s)
Cesaro S., Mikulska M., Hirsch H.H., Styczynski J., Meylan S., Cordonnier C., Navarro D., von Lilienfeld-Toal M., Mehra V., Marchesi F., Besson C., Masculano R.C., Beutel G., Einsele H., Maertens J., de la Camara R., Ljungman P., Pagano L.
Working group(s)
ECIL 9
Contributor(s)
von Lilienfeld-Toal M., de la Camara R.
ISSN
1476-5551 (Electronic)
ISSN-L
0887-6924
Publication state
Published
Issued date
09/2023
Peer-reviewed
Oui
Volume
37
Number
9
Pages
1933-1938
Language
english
Notes
Publication types: Letter
Publication Status: ppublish
Keywords
Humans, Receptors, Chimeric Antigen, COVID-19, Leukemia/complications, Leukemia/therapy, Hematologic Neoplasms/complications, Hematologic Neoplasms/therapy, Hematopoietic Stem Cell Transplantation/adverse effects
OAI-PMH
oai:serval.unil.ch:BIB_68C8171C3E09
DOI
10.1038/s41375-023-01938-5
Pubmed
37460673
Web of science
001033010100001
Open Access
Yes
Create date
21/07/2023 12:07
Last modification date
19/12/2023 8:15
Usage data